Sensorimotor Gating Depends on Polymorphisms of the Serotonin-2A Receptor and Catechol-O-Methyltransferase, but Not on Neuregulin-1 Arg38Gln Genotype: A Replication Study
Received 2 February 2009; received in revised form 12 May 2009; accepted 12 May 2009. published online 22 June 2009.
Background
Prepulse inhibition (PPI) of the acoustic startle response (ASR) is an operational measure of sensorimotor gating and a promising endophenotype of schizophrenia. We have recently shown that the linked serotonin-2A receptor (5-HT2AR) A-1438 G and T102C polymorphisms modulate PPI in schizophrenia patients. Moreover, it was shown that genetic variation in the catechol-O-methyltransferase (COMT) and the neuregulin-1 (NRG-1) proteins influences PPI in schizophrenia patients and healthy volunteers. Therefore, we aimed to replicate these results and investigated the impact of the related polymorphisms on PPI in healthy human volunteers.
Methods
We analyzed the 5-HT2AR A-1438 G/T102C (rs6311/rs6313), the COMT Val158Met (rs4680), and the NRG-1 Arg38Gln (rs3924999) polymorphisms, assessing startle reactivity, habituation, and PPI of ASR in 107 healthy Caucasian volunteers.
Results
Subjects homozygous for the 5-HT2AR T102C-T/A-1438 G-A allele showed increased PPI levels. In particular, male subjects with the COMT Met158Met-genotype also showed elevated PPI. The NRG-1 Arg38Gln genotype did not have a significant impact on PPI. Startle reactivity was not affected by any of the investigated polymorphisms.
Conclusions
We confirmed in an independent sample of healthy volunteers that PPI is influenced by genetic variation in the 5-HT2AR gene. The influence of the COMT Val158Met genotype on PPI appears to be sex-specific. These results underscore the significance of the serotonin and dopamine systems in the modulation of sensorimotor gating.
aDepartment of Psychiatry, University of Bonn, Germany
bUniversity Hospital of Psychiatry, Division of Neuropsychopharmacology and Brain Imaging, University of Zurich, Switzerland
cDepartment of Psychology, Institute of Psychiatry and National Institute for Health Research (NIHR), Biomedical Research Centre for Mental Health, King's College London, London, United Kingdom
dDepartments of Psychiatry and Psychology, Ludwig-Maximilians-University, Munich, Germany
eSocial, Genetic and Developmental Psychiatry Research Centre, Institute of Psychiatry and NIHR Biomedical Research Centre for Mental Health, King's College London, United Kingdom
Address correspondence to Boris B. Quednow, Ph.D., Dipl.-Psych., University Hospital of Psychiatry, Experimental and Clinical Pharmacopsychology, Lenggstrasse 31, CH-8032 Zurich, Switzerland
ABSTRACT